SK ecoplant Co. plans to develop a technology to produce hydrogen through a fermentation process where microorganisms eat and decompose organic matter in the absence of light
When compared to the current approach of extracting methane gas from organic waste resources and then reforming it into hydrogen, this technology can cut the time needed for the manufacture of hydrogen by more than 20 times.
Additionally, because it does not require a reforming process that demands a high temperature of more than 1,000 degrees Celsius, it can lower the number of fossil fuels needed to create a high-temperature environment.
The South Korean builder will jointly carry out the state project “Future Hydrogen Original Technology Development” launched by the National Research Foundation of Korea.
SK ecoplant will be in charge of doing market and patent research as well as choosing the organic waste resources that will be used to produce hydrogen.


How to create a thriving forest, not box-checking ‘tree cover’
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
The UK is surprisingly short of water – but more reservoirs aren’t the answer
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Extreme heat, flooding, wildfires – Colorado’s formerly incarcerated people on the hazards they faced behind bars
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Thailand Inflation Remains Negative for 10th Straight Month in January
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
We combed through old botanical surveys to track how plants on Australia’s islands are changing
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Neuralink Expands Brain Implant Trials with 12 Global Patients
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 



